Frovatriptan succinate hydrate

SKU: orb1309659

Description

Frovatriptan succinate hydrate is a selective 5-HT1B/1D and 5-HT7 receptor agonist used in migraine research. It is effective against acute migraine attacks and associated symptoms, with studies supporting its use for menstrual migraine prophylaxis. Its pharmacological profile makes it a valuable tool for in vitro binding assays and in vivo models of trigeminovascular activation.

Research Area

Neuroscience, Pharmacology & Drug Discovery

Key Properties

• CAS Number: 158930-17-7
• MW: 379.41
• Purity: 99.66% (May vary between batches)
• Formula: C₁₈H₂₅N₃O₆
• SMILES: O.OC(=O)CCC(O)=O.CN[C@@H]1CCc2[nH]c3ccc(cc3c2C1)C(N)=O
• Target: 5-HT Receptor
• Solubility: DMSO:60 mg/mL (158.14 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.27 mM)

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

carotid, 5-HT1D Receptor, 5-HT1B Receptor, 5-HT1D, 5HT Receptor, 5-HT Receptor, 5-HT1B, 5-hydroxytryptamine Receptor, 5HTReceptor, 5-HT7, (R)-Frovatriptan succinate, Frova, Frovatriptan succinate, Frovatriptan succinate hydrate, Frovatriptan succinate Hydrate, Frovelan, Human 5-HT7 Receptor, menstrual, Inhibitor, nausea, migraine, orally, inhibit, SB 209509 succinate, Serotonin Receptor, phonophobia, photophobia, vascular, vomiting, VML 251 succinate

Quick Database Links

Gene Symbol

5-HT Receptor